Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
Telitacicept yields ‘really exciting’ results in rheumatoid arthritis structural damage
SAN DIEGO — Patients treated with telitacicept demonstrated improvements in American College of Rheumatology response and structural damage in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2023.
‘On the cusp’ of something big: New insights into the microbiome’s role in immunity
As of just a few years ago, early enthusiasm over the apparent interplay between the gut microbiome and the immune system, and that it was driving or exacerbating certain rheumatic diseases, seemed to have all but dried up.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Plant-rich diet can decrease flares in rheumatoid arthritis
SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a presentation from ACR Convergence 2023 that assessed the impact of diet on patients with rheumatoid arthritis and lupus.
VIDEO: Patient perspective may help to predict or measure flares in rheumatoid arthritis
SAN DIEGO — In this video, Kathryn Dao, MD, spoke with Healio about patient-reported outcomes from the ARCTIC REWIND study presented at ACR Convergence 2023.
VIDEO: ‘Don’t taper’ TNF inhibitors for patients with RA in sustained remission
SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a study assessing the effects of tapering to withdraw of TNF inhibitors compared with stable use among patients with rheumatoid arthritis.
VIDEO: TNF inhibitors appear safe for patients with RA-associated ILD
SAN DIEGO — Kathryn Dao, MD, discusses a study presented at ACR Convergence 2023 that compared the initiation of TNF inhibitors with non-TNF inhibitor biologics or JAK inhibitors among patients with rheumatoid arthritis-associated interstitial lung disease.
VIDEO: Efficacious split-dosing of high-dose methotrexate in patients with RA
SAN DIEGO — In this video, Healio spoke with Kathryn Dao, MD, about the SMART study presented at ACR Convergence 2023.
Split-dose methotrexate lowers need for more DMARDs vs single dose in rheumatoid arthritis
SAN DIEGO — Split-dose methotrexate had greater efficacy and reduced the need for additional disease-modifying antirheumatic drugs at 16 weeks vs. a single dose for rheumatoid arthritis, according to data presented at ACR Convergence 2023.
Patients with rheumatoid arthritis report ‘many symptoms’ of long COVID prior to infection
SAN DIEGO — Patients with rheumatoid arthritis who reported having long COVID in the past year demonstrated “many symptoms” of long COVID prior to initial infection,” according to data presented at ACR Convergence 2023.
PCP training improves rheumatoid arthritis care in underserved Native American populations
SAN DIEGO — A 12-week, remote training program improved rheumatoid arthritis knowledge and clinical behaviors among PCPs in underserved Native American populations across the United States, according to speaker at ACR Convergence 2023.
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read
-
Headline News
FDA warns of potential liver injury with Veozah for menopausal hot flashes
September 12, 20242 min read -
Headline News
Video games improved mental health during COVID-19 pandemic
September 12, 20242 min read -
Headline NewsSeptember 12, 20240 min read